PYC Therapeutics takes Polycystic Kidney Disease drug to human trials
PYC Therapeutics (ASX:PYC) has completed Dose Range Finding (DRF) studies for its…
Pyc Therapeutics Limited (ASX:PYC)
About Pyc Therapeutics Limited
Key Information
PYC In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 22/04/2024 | Price Sensitive PS Kidney Disease Drug Candidate Progressing to Human Trials | 280.51KB | 6.6K |
| 17/04/2024 | Change in substantial holding | 193.75KB | 1.9K |
| 15/04/2024 | Update - Application for quotation of securities - PYC | 15.66KB | 249 |
| 12/04/2024 | Application for quotation of securities - PYC | 14.27KB | 307 |
| 11/04/2024 | Change in substantial holding | 101.29KB | 364 |
| 10/04/2024 | Price Sensitive PS $74.6 Million Extension of Cash Runway | 248.55KB | 4.7K |
| 03/04/2024 | Notification of cessation of securities - PYC | 12.93KB | 333 |
| 28/03/2024 | Change of Director's Interest Notice | 224.9KB | 3.8K |